Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target

RL Jensen - Journal of neuro-oncology, 2009 - Springer
Hypoxia is implicated in many aspects of tumor development, angiogenesis, and growth in
many different tumors. Brain tumors, particularly the highly aggressive glioblastoma …

Glioblastoma-initiating cells: relationship with neural stem cells and the micro-environment

N Goffart, J Kroonen, B Rogister - Cancers, 2013 - mdpi.com
Glioblastoma multiforme (GBM, WHO grade IV) is the most common and lethal subtype of
primary brain tumor with a median overall survival of 15 months from the time of diagnosis …

A high-performance nanobio photocatalyst for targeted brain cancer therapy

EA Rozhkova, I Ulasov, B Lai, NM Dimitrijevic… - Nano …, 2009 - ACS Publications
We report pronounced and specific antiglioblastoma cell phototoxicity of 5 nm TiO2 particles
covalently tethered to an antibody via a dihydroxybenzene bivalent linker. The linker …

Diagnostic performance of texture analysis on MRI in grading cerebral gliomas

K Skogen, A Schulz, JB Dormagen, B Ganeshan… - European journal of …, 2016 - Elsevier
Background and purpose Grading of cerebral gliomas is important both in treatment
decision and assessment of prognosis. The purpose of this study was to determine the …

FLAIRectomy in supramarginal resection of glioblastoma correlates with clinical outcome and survival analysis: a prospective, single institution, case series

F Certo, R Altieri, M Maione, C Schonauer… - Operative …, 2021 - journals.lww.com
Background Extent of tumor resection (EOTR) in glioblastoma surgery plays an important
role in improving survival. Objective To analyze the efficacy, safety and reliability of fluid …

Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization

J Fierro Jr, J DiPasquale, J Perez, B Chin… - Scientific Reports, 2022 - nature.com
Programmed death ligand 1 (PD-L1) plays a key role in glioblastoma multiforme (GBM)
immunosuppression, vitality, proliferation, and migration, and is therefore a promising target …

Glioblastoma multiforme metastasis outside the CNS: three case reports and possible mechanisms of escape

JD Hamilton, M Rapp, TM Schneiderhan… - Journal of Clinical …, 2014 - ascopubs.org
Primary brain and CNS tumor incidence is approximately 19 per 100,000 individuals per
year in the United States compared with seven per 100,000 individuals worldwide. 1, 2 …

Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion

B Annabi, MP Lachambre, K Plouffe… - Pharmacological …, 2009 - Elsevier
In recent clinical observation, the growth of endothelial tumors, such as hemangiomas of
infancy, was repressed by the non-selective β-adrenergic antagonist propranolol possibly …

Chi3l1 is a modulator of glioma stem cell states and a therapeutic target in glioblastoma

C Guetta-Terrier, D Karambizi, B Akosman, JP Zepecki… - Cancer research, 2023 - AACR
Abstract Chitinase 3–like 1 (Chi3l1) is a secreted protein that is highly expressed in
glioblastoma. Here, we show that Chi3l1 alters the state of glioma stem cells (GSC) to …

Mathematical modeling of brain tumors: effects of radiotherapy and chemotherapy

G Powathil, M Kohandel… - Physics in Medicine …, 2007 - iopscience.iop.org
Gliomas, the most common primary brain tumors, are diffusive and highly invasive. The
standard treatment for brain tumors consists of a combination of surgery, radiation therapy …